Showing results (41-50 of 689) with videos related to
Sort By:
Pageof 69
Diabetes, Obesity & Metabolism|July 2, 2024
Randomised comparison of intravenous and subcutaneous routes of glucagon-like peptide-1 administration for lowering plasma glucose in hyperglycaemic subjects with type 2 diabetesDaniel R Quast, Dara Lancaster, Cong Xie, et al.Acta Diabetologica|December 19, 2019
The relationship between plasma GIP and GLP-1 levels in individuals with normal and impaired glucose toleranceChinmay S Marathe, Hung Pham, Jessica A Marathe, et al.Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|March 1, 2022
Measurement of Gastric Emptying Using a 13C-octanoic Acid Breath Test with Wagner-Nelson Analysis and Scintigraphy in Type 2 DiabetesLaurence G Trahair, Michael A Nauck, Tongzhi Wu, et al.Diabetes Care|September 10, 2020
Efficacy and Safety of Short- and Long-Acting Glucagon-Like Peptide 1 Receptor Agonists on a Background of Basal Insulin in Type 2 Diabetes: A Meta-analysisJessica A Huthmacher, Juris J Meier, Michael A NauckBMC Medicine|July 3, 2024
Long-term comparison of renal and metabolic outcomes after sodium-glucose co-transporter 2 inhibitor or glucagon-like peptide-1 receptor agonist therapy in type 2 diabetesMinji Sohn, Seoungyeon Nam, Michael A Nauck, et al.Endocrinology and Metabolism (Seoul, Korea)|November 25, 2024
Metabolic Consequences of Glucagon-Like Peptide-1 Receptor Agonist Shortage: Deterioration of Glycemic Control in Type 2 DiabetesHun Jee Choe, Michael A Nauck, Joon Ho MoonJournal of Diabetes Science and Technology|August 19, 2020
Patients with Type 1 Diabetes Treated with Insulin Pumps Need Widely Heterogeneous Basal Rate Profiles Ranging from Negligible to Pronounced Diurnal VariabilityAnna M Lindmeyer, Juris J Meier, Michael A NauckDiabetes, Obesity & Metabolism|February 27, 2026
Dose-Escalation Regimens for Incretin Mimetics in Type 2 Diabetes Are Associated With Tolerance for Nausea and VomitingMichael A Nauck, Viktoria Punov, Yu Mi Kang, et al.Diabetes|January 6, 2025
Effects of Metformin on Postprandial Blood Pressure, Heart Rate, Gastric Emptying, GLP-1, and Prevalence of Postprandial Hypotension in Type 2 Diabetes: A Double-Blind Placebo-Controlled Crossover StudyDaniel R Quast, Cong Xie, Michelle J Bound, et al.Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|June 29, 2019
Owning a Dog as a Determinant of Physical Activity and Metabolic Control in Patients With Type 1 and Type 2 Diabetes MellitusJulia Riske, Martin Janert, Melanie Kahle-Stephan, et al.Pageof 69